Bluewater Bio, a leading provider of innovative high-performance, cost-effective water and wastewater treatment technologies, is pleased to announce that it has entered into a licensing agreement with NeoTech Aqua Solutions, Inc. (“NeoTech”) to market their ultra- efficient, highly advanced UV technologies to industrial and municipal clients. The license is global, with exclusive territory rights that include the UK and Ireland.
BwB believe there is an excellent growth market for efficient UV technology in territories that they or their partners currently operate in. The key drivers for UV adoption are primarily its ability to disinfect harmful pathogens in potable water, including Cryptosporidium and E.coli, and the conscious effort to move away from using chlorine for safety and environmental reasons. Major catalysts for UV market growth are cost, water scarcity, public health, demand for high purity process water, reuse/recycling and environmental compliance.
NeoTech, based in San Diego, California, USA, have already proven their patented ultra-efficient UV technology in over 300 installations; selling into the food & beverage, bottled water, pharmaceutical, pools & water parks, microelectronics, wastewater, remediation, and municipal drinking water markets – both for disinfection and for the elimination of organic contaminants (TOC).
NeoTech’s UV technology utilises a patented chamber design combined with ReFleX™ technology which reflects over 99% of the UV generated back into the treated water, continuously until the target contaminant is destroyed. By comparison, conventional UV systems typically reflect only about a quarter of the UV generated. NeoTech’s technical advantages eliminate most of the electrical power and number of lamps required to treat a given volume of water, translating to lower operating costs, a 75% smaller footprint, less lamp and
sleeve maintenance, and a unique ability to remain powered on even if water flow is interrupted. Furthermore, NeoTech’s UV systems may be mounted in any configuration and no tools are required for lamp replacement.
BwB, established in 2007 to develop their patented HYBACS® process, have since seen their product portfolio grow to include FilterClear™, a high performance multimedia filtration technology, and GHG-Tox®, an innovative nitrification and greenhouse gas monitoring system. NeoTech aligns perfectly with BwB’s technology aggregation strategy; developing a global mid-market platform for innovative, high performance, low cost water and wastewater treatment products. Whilst each of these solutions can deliver significant performance improvements in isolation, their commercial benefits to municipal and industrial users are even more compelling when combined.
For example, Bluewater Bio’s FilterClear™ range of high performance filtration technologies achieves world class performance; removing particulates from clean water and wastewater in both municipal and industrial settings. Neotech UV and FilterClear™ together are ideal complementary technologies for ultra-efficient filtration and subsequent disinfection.
NeoTech’s President/CEO, Stephen Dunham said: “The NeoTech team welcomes the opportunity to move forward globally in cooperation with Bluewater Bio. The synergistic advantages of leveraging BlueWater Bio’s existing technology, global footprint and corporate assets with NeoTech’s unique technological strengths in UV renders a new, multi-faceted capability that will benefit both companies and particularly the market at large. This is an exciting time of expansion for our respective technologies.”
Daniel Ishag, Founder & CEO of Bluewater Bio International commented: “I would like to take this opportunity to thank both teams for their effort in bringing this deal to fruition. As we look to increase our product platform and service the needs of our ever increasing customer base, this deal signifies an important step in realising that aim. We aspire to be the world’s leading independent water technology provider. I strongly believe that, with Neotech onboard, we are ever closer to achieving this.”
(original article by Robert Jobson, Evening Standard, 11 November 2016) Prince Charles’s state visit to the Gulf has...
Bluewater Bio Limited is pleased to announce that Severn Trent Water , through its key capital delivery partner MWH Treatment...